glutamine has been researched along with Malignant Neurilemmoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, JMH; Ali, ES; Alt, J; Asara, JM; Ben-Sahra, I; Krecmerova, M; Lemberg, KM; Majer, P; Nuha, N; Peters, DE; Pratilas, CA; Rais, R; Slusher, BS; Staedtke, V; Wu, Y; Zhao, L | 1 |
1 other study(ies) available for glutamine and Malignant Neurilemmoma
| Article | Year |
|---|---|
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.
Topics: Animals; Antimetabolites; Cell Line, Tumor; Glutamine; Humans; Mice; Nerve Sheath Neoplasms; Neurofibrosarcoma | 2023 |